Auscann Group Holdings Ltd ACNNF

Healthcare

AusCann Group Holdings Limited is an Australia-based company focused on the development and commercialization of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. It has launched tetrahydrocannabinol and cannabidiol (THC/CBD) powder-based hard-shell capsules, based on the Company’s Neuvis platform, for the treatment of pain and related indications. Its products include CPAT-01, DermaCann and MicroMax. CPAT-01 is a liquid, oral veterinary medicine containing standardized tetrahydrocannabinol (THC) and cannabinoids (CBD) whole plant extracts in a proprietary ratio to target pain and inflammation in dogs. DermaCann is a CBD-derived nutraceutical in development for healthy skin and immune function in dogs with dermatological conditions. The product is a liquid oral oil formulation containing CBD in a patented combination with other bioactive lipids designed to target inflammation and immune modulation pathways.

OTCPK:ACNNF - Post by User

Auscann Group Holdings Ltd > Australian opportunities

<< Previous

Bullboard Posts

Next >>

Post by 100million4meon Apr 30, 2018 7:31pm

279 Views

Post# 27961667

Australian opportunities

With Australia only recently legalizing medical, and very few patient numbers, I’m thinking lots of growth potential ... AusCann and ? another company with a connection to ACB... look like contenders... with global cannabis growth, Australian market should increase exponentially over next 10 years? Even 5, imo

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects